Levodopa response in pathology-confirmed Parkinson’s Disease, Multiple System Atrophy and Progressive Supranuclear Palsy
Objective: to describe the rate of levodopa response, phenotypical characteristics, prognostic implications and pathological features in a large cohort of patients with pathology-confirmed Parkinson’s disease…Parkinson’s Disease and Cancer: A Meta-Analysis of Prevalence, Risk, and Specific Associations with Brain and Skin Cancers
Objective: To update the available data on the prevalence of cancer among patients with Parkinson’s Disease (PD) and the prevalence of PD among cancer patients…Frequency of Falls in the Parkinson’s Progression Markers Initiative
Objective: To determine the faller rate across years since diagnosis and neuronal α-synuclein disease integrated staging system (NSD-ISS) stages in the Parkinson's Progression Markers Initiative…Finding Prodromal Parkinson’s Disease with the Movement Disorder Society’s Prodromal Calculator and Electronic Health Records
Objective: To explore the ability for electronic health records to identify persons with prodromal Parkinson’s disease in a cohort of those with RBD in the…Tendencies of Non-Motor Symptoms and Short-Term Clinical Predictors in Patients with Parkinson’s Disease
Objective: This study retrospectively investigated whether the occurrence of non-motor symptoms and the decline in cognitive function in patients with Parkinson’s disease (PD) influence fall…Association between cognitive adverse effects of anticholinergic medication and development of long-term dementia in Parkinson’s disease
Objective: To investigate whether cognitive adverse effects occurring immediately after taking anticholinergics are related to the development of long-term dementia and to interpret this from…PINK1 activation improves outcomes in the UQCRC1 models of Parkinson’s disease
Objective: To investigate the role of chronic oxidative phosphorylation (OXPHOS) stress in mitophagy and the therapeutic potential of PINK1 activation in the UQCRC1 models of…Moyamoya Disease and the Risk of Parkinson’s Disease
Objective: We aimed to determine whether the risk of Parkinson’s disease (PD) is increased in patients with Moyamoya disease (MMD) and to identify the potential…Decoding Parkinson’s Progression: Longitudinal Volumetric MRI Biomarkers in Prodromal and Clinical Stages
Objective: This study investigates MRI volumetric analysis via VBM as a biomarker for early PD detection, focusing on structural alterations in deep gray matter regions…Contribution of Dopamine Depletion, Cerebral Perfusion, and Cognition to Gait Dysfunction in Parkinson’s Disease
Objective: To explore the potential contribution of dopamine loss, perfusion deficit, and cognition to spatiotemporal gait parameters in patients with Parkinson's disease (PD). Background: Gait…
- « Previous Page
- 1
- …
- 83
- 84
- 85
- 86
- 87
- …
- 181
- Next Page »